Exploring VISTA and LRIG1 Interactions: Cancer Immunotherapy

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

3 Common Myths About Suicide - #526 13 min · 18 Sep 2026 · Something For Everybody

How OpenAI Built a Billion-Dollar Ad Engine 12 min · 18 Sep 2026 · WSJ Tech News Briefing

House of HorroR: Resident Evil 1h 24m · 18 Sep 2026 · House of R

Do This (It’s Good For Your Sanity) | A Garden Is Not For Show 9 min · 18 Sep 2026 · The Daily Stoic

Report any issue

Source

Recorded22 Aug 2024

Publisherfeeds.buzzsprout.com

Handlerec:1648174

Show notes

Lily Wang, PhD, from the Department of Translational Hematology Oncology Research at Cleveland Clinic, joins the Cancer Advances Podcast to dive into her research on VISTA and LRIG1 interactions. Dr. Wang, an expert in immune mechanisms within cancer, discusses her lab's innovative work on these immune checkpoint proteins and their potential to overcome current treatment limitations. Discover how targeting the VISTA-LRIG1 axis could offer new strategies for tackling resistant tumors and improving patient outcomes.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in